Exponent Q2 Revenue Soars 21%, Beats by $24M; Raises Full-Year Outlook
EXPO sits 24% above its 52-week low of $51.91.
Summary
Exponent delivered a standout Q2: revenue of $171.6M crushed the $147.55M consensus, driven by surging demand for AI-related user research and utility infrastructure work. EPS hit $0.60, net income $29.4M, and EBITDA $42.7M. Management raised full-year revenue growth guidance to 9-10% and set Q3 growth at 8-10%, with EBITDA margins holding in the 28% range. The board also added $50M to the buyback program, signaling confidence. This follows a strong Q1 and extends the momentum — the stock, trading at 27x forward earnings, now has a clear path to the $82.50 analyst target.
At the time of this announcement, EXPO was trading at $64.57 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $51.91 to $81.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.